immune systems, suggesting that inflammation may be modulated by vitamin D. 8, 9 As argued in the review by Stein et al, 10 vitamin D could exert its "perio-protective" role by shaping both the innate and the adaptive immune response, thus favoring resolution of the inflammation.
Analysis of cross-sectional data of the third National Health and Nutrition Examination Survey (NHANES III) found that the serum concentrations of 25-hydroxyvitamin D (25(OH)D) were significantly and inversely associated with bleeding on gingival probing in all age groups. 11 Dietrich et al 12 also reported an inverse association with clinical attachment loss in men and women aged 50 years or older.
Recent evidence from a case-control study by Boggess et al 13 reported decreased serum levels of vitamin D associated with maternal periodontal disease during pregnancy, and the same was true for the periodontitis in postmenopausal women with osteoporosis. loss in elderly men and women. 16 Likewise, periodontal maintenance patients taking calcium and vitamin D supplements had better periodontal health, than those who did not. 17 Moreover, Hujoel et al, in a systematic review of controlled clinical trials, suggested that supplemental vitamin D was associated with a 47% reduced risk of caries. What is more, higher overall study quality score translated into higher vitamin D effectiveness. For instance, restricting the analysis to studies with nonbiased treatment assignment increased the percentage reduction in caries rate from 47% to 54%. 18 These findings might suggest a protective and beneficial effect of vitamin D on oral health and periodontal condition.
Therefore, the focus of this systematic review was to find the evidence that could support or reject the possible impact of vitamin D serum levels in the etiology and therapy of periodontal diseases.
Hence, two focused PICO questions were created: However, because of the paucity and methodological heterogeneity of the published studies, which strongly differed in at least one of the PICO parameters (thus making any comparison and regrouping ineffective), the second question could not have been assessed in an evidence-based manner according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 19 statement and was therefore excluded from the current systematic review.
| MATERIAL AND ME THODS

| Protocol
This systematic review was prepared according to the 27-item PRISMA Checklist. 19 Furthermore, the Assessment of Multiple Systematic Reviews guidelines (AMSTAR) 20 was followed.
The protocol is registered at the International Prospective
Register of Systematic Reviews (PROSPERO) under the number CRD42017064420 (available from: http://www.crd.york.ac.uk/ PROSPERO/display_record.php?ID=CRD42017064420).
| Study design
The protocol was developed in advance with the following focused PICO question:
Are serum vitamin D levels (I) associated with gingivitis or periodontitis (O) in healthy humans (P)?
Population: healthy humans
Intervention: participants with normal serum vitamin D levels
Comparison: participants with serum vitamin D deficiency
Outcome: gingivitis or periodontitis
| Eligibility criteria
| Inclusion criteria
• Randomized clinical trials, controlled clinical trials, observational studies (case series, cohort studies, and cross-sectional studies)
• Adult Caucasian population (≥18 years)
• Patients without systemic diseases or medications 
| Exclusion criteria
• Not original studies (eg reviews), case reports, retrospective studies and case series
• Nonhuman studies (in vitro studies and studies on animal models)
• Patients diagnosed with aggressive periodontitis The search was performed using a combination of controlled vocabulary and key words. Details regarding the search strategy are presented in Table S1 .
References were managed via reference manager software (EndNote X7; Thomson Reuters, Philadelphia, PA, USA).
| Study selection and data collection process
Studies fulfilling all the eligibility criteria were processed for data extraction. Predefined data extraction forms were used for assessment of each publication. Data were collected independently by one author (MP) and confirmed by a second author (JFL). When the study results were published more than once, the most complete data set was identified and included.
| Risk of bias in individual studies
Risk of bias in individual studies/quality assessment was carried out by two of the authors (MP and JFL) independently.
Disagreements were resolved by discussion until a consensus was reached. The Newcastle-Ottawa Scale (NOS) 21 was followed to assess case-control studies. In order to evaluate the methodological quality of the included cross-sectional studies, a modified NOS 22 was used.
F I G U R E 1 Prisma flow chart of literature search and inclusion From: Moher et al. 19 For more information, visit www.prisma-statement.org 
| RE SULTS
| Study selection
A total of 365 studies was identified through the electronic search.
Manual search did not determine any further study for inclusion. 
| Description of characteristics of included studies
All information related to study characteristics and data synthesis are presented in Table 1 . Four of the studies were of a case-control design, one was an experimental study (uncontrolled trial), whereas the remaining two had a cross-sectional design. Therefore, none corresponded to the highest level of quality-randomized controlled trial.
| Quality assessment using the NOS
All 7 studies were assessed using the NOS for case series and the modified NOS for cross-sectional design. The consensus NOS quality score for each study is depicted in the Appendixes S4, S5.
Major bias in these studies was risk of bias in selection of samples because the study population derived mostly from hospital settings and dental schools. Moreover, the blinding of the examiners was not reported in the studies.
Cofounders, such as age, sex, body mass index, and smoking status were reported, except for the study of Eshghi et al. 23 Nonetheless, they were not systematically adjusted for in the 24, 25 Periodontal condition was defined by clinical examination, but the examiner's calibration was only reported in the studies from
Teles et al 26 and Abreu et al. 27 However, calibration modalities were not specified.
Serum vitamin D levels were evaluated by laboratory tests listed in Table 1 Seventeen patients were examined at 6 mo after therapy. There were essentially no differences between pretreatment and post-treatment levels of any of the serum analytes, although a trend toward the reduction of TNF-a and increase in vitamin D and adiponectin was detected.
| D ISCUSS I ON
All clinical parameters of periodontitis showed improvement after periodontal therapy. In addition, levels of the periodontal pathogens Tannerella forsythia, Treponema denticola, and Porphyromonas gingivalis were considerably reduced after treatment None of the clinical or microbial parameters were associated with any of the serum analytes (P > .05). Using multiple linear regression, it was observed that the best predictors for adiponectin levels were sex (female), BMI (lower), and increasing age (P = .000 078, r 2 = 0.278).
For leptin levels, the best predictors were sex (female) and BMI (higher) (P = .000001, r 2 = 0.789).
BMI was the only significant predictor for IL-6 (P = . Assessment Scheme. 32 Additionally, the study populations derive mostly from hospitals, except for that in Antonoglou et al, 25 with a small sample size and without defining the study power, except for Laky et al. 33 Furthermore, comparability of the cases and controls on the basis of the design in case-control studies was rated as low.
Regarding the association between serum vitamin D levels and 
| Clinical relevance
There 
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